Multiple Sclerosis Trial, Recruiting NCT05355389 Sponsor: Universitair Ziekenhuis Brussel Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

NCT05355389
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been officially diagnosed with multiple sclerosis (MS) using recognised diagnostic guidelines
  • Your MS has not severely affected your ability to walk or move around (below a certain level on a standard disability scale — confirm exact level with trial site)
  • You have some memory or concentration difficulties, but not extremely severe ones, as measured by a specific memory test (confirm with trial site)
  • You are between 18 and 65 years old
  • You are able to safely do physical rehabilitation exercises at home, as confirmed by a rehabilitation doctor or therapist

Who may not be able to join:

  • You have taken part in cognitive (thinking or memory) rehabilitation within the last 6 months
  • You have completed or are planning an inpatient rehabilitation programme within 3 months before joining the trial
  • You have recently started or changed your MS medication within the last 3 months
  • You have had an MS relapse (flare-up) within the last month
  • You have a significant mental health condition or other serious medical condition that could affect your thinking or memory
  • Your vision, even with glasses or contact lenses, does not meet a minimum level on a standard eye test
  • You are unable or unwilling to have brain scans (MRI) or brain activity recordings (EEG)
  • You do not wish to give your formal consent to take part

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Guy Nagels, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel

Phone: +32 2 629 10 45

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Universitair Ziekenhuis Brussel
Registry
ClinicalTrials.gov
Start date
1 September 2022
Est. completion
31 August 2027

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

Change in Digit span backwards

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov